Literature DB >> 1657625

Prevalence of cytomegalovirus infection in Italy.

D de Mattia1, T Stroffolini, S Arista, D Pistoia, A Giammanco, M Maggio, M Chiaramonte, M E Moschen, I Mura, G Rigo.   

Abstract

Between 1987 and 1989, the prevalence of antibody to cytomegalovirus (CMV) was determined, by the ELISA method, in serum samples from 1494 apparently healthy subjects, 3-18 years old. Subjects were selected by a systematic cluster sampling from five geographical areas in Italy. The overall prevalence of antibody was 64.2%, increasing from 54.4% in 4-6-year-olds to 73.3% in subjects 17-18 years old (P less than 0.01). Prevalence of antibody was significantly higher in females (P less than 0.05) and in subjects residing in the South of Italy (P less than 0.01). A significant association was found with sociodemographic factors. Subjects belonging to a household with six or more persons had a 1.5-fold risk (C.I. 95% = 1.11-2.04) and subjects whose fathers had less than 6 years of schooling had a 1.4-fold risk (C.I. 95% = 1.1-1.87) of previous exposure to CMV infection. The high prevalence (74.4%) of young women who are naturally immune when entering childbearing years does not guarantee that there will be a low risk of fetal infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657625      PMCID: PMC2272074          DOI: 10.1017/s0950268800049062

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  13 in total

1.  Prevalence of cytomegalovirus antibody in subjects between the ages of 6 and 22 years.

Authors:  N H White; M D Yow; G J Demmler; H J Norton; J Hoyle; K Pinckard; C Mishaw; S Pokorny
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

Review 2.  Epidemiology and transmission of cytomegalovirus.

Authors:  R F Pass
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

3.  Acquisition of cytomegalovirus infection from birth to 10 years: a longitudinal serologic study.

Authors:  M D Yow; N H White; L H Taber; A L Frank; W C Gruber; R A May; H J Norton
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

4.  Cytomegalic inclusion disease after recurrent maternal infection.

Authors:  D Rutter; P Griffiths; R S Trompeter
Journal:  Lancet       Date:  1985-11-23       Impact factor: 79.321

5.  Secondary maternal cytomegalovirus infection causing symptomatic congenital infection.

Authors:  K Ahlfors; S Harris; S Ivarsson; L Svanberg
Journal:  N Engl J Med       Date:  1981-07-30       Impact factor: 91.245

6.  Breast milk and the risk of cytomegalovirus infection.

Authors:  S Stagno; D W Reynolds; R F Pass; C A Alford
Journal:  N Engl J Med       Date:  1980-05-08       Impact factor: 91.245

7.  Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome.

Authors:  S Stagno; R F Pass; G Cloud; W J Britt; R E Henderson; P D Walton; D A Veren; F Page; C A Alford
Journal:  JAMA       Date:  1986-10-10       Impact factor: 56.272

8.  Prevalence survey of cytomegalovirus infection in children in Chengdu.

Authors:  Z Liu; E Wang; W Taylor; H Yu; T Wu; Z Wan; Y Huang; Z Ni; D Sackett
Journal:  Am J Epidemiol       Date:  1990-01       Impact factor: 4.897

9.  Congenital cytomegalovirus infection.

Authors:  S Stagno; D W Reynolds; E S Huang; S D Thames; R J Smith; C A Alford
Journal:  N Engl J Med       Date:  1977-06-02       Impact factor: 91.245

Review 10.  Epidemiology of cytomegaloviral infections: recommendations for prevention and control.

Authors:  I M Onorato; D M Morens; W J Martone; S K Stansfield
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug
View more
  6 in total

1.  Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010.

Authors:  Gisela Enders; Anja Daiminger; Lisa Lindemann; Frank Knotek; Ursula Bäder; Simone Exler; Martin Enders
Journal:  Med Microbiol Immunol       Date:  2012-03-08       Impact factor: 3.402

2.  Cytomegalovirus seroprevalence in exposed and unexposed populations of hospital employees.

Authors:  N Lepage; A Leroyer; N Cherot-Kornobis; I Lartigau; S Miczek; A Sobaszek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-15       Impact factor: 3.267

Review 3.  The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer.

Authors:  Xiao-Hua Luo; Qingda Meng; Martin Rao; Zhenjiang Liu; Georgia Paraschoudi; Ernest Dodoo; Markus Maeurer
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

4.  Cytomegalovirus anterior uveitis: long-term follow-up of immunocompetent patients.

Authors:  M Accorinti; M Gilardi; M P Pirraglia; G M Amorelli; C Nardella; I Abicca; F R Pesci
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-20       Impact factor: 3.117

5.  Seroprevalence of antibodies to cytomegalovirus in pregnant women in the Apulia region (Italy).

Authors:  Claudia Maria Trombetta; Simonetta Viviani; Emanuele Montomoli; Serena Marchi
Journal:  J Prev Med Hyg       Date:  2021-07-30

6.  Incidence and risk of cytomegalovirus infection during pregnancy in an urban area of Northern Italy.

Authors:  Massimo De Paschale; Carlo Agrappi; Maria Teresa Manco; Alessia Paganini; Pierangelo Clerici
Journal:  Infect Dis Obstet Gynecol       Date:  2009-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.